School of Medicine Homepage
Emory University Shield
  • About
    • Our Vision
    • Academic Departments
    • Our Leadership
    • Health Care Partnerships
    • Diversity, Equity, & Inclusion
    • Location
    • Supporting Our People
    • Our Faculty
    • History
    • News
    • Events
    • Contact Us
  • Education
    • Degree and Certificate Programs
    • Academic Departments
    • Residents & Fellows
    • Postdoctoral Training
    • Continuing Medical Education
    • Admissions
    • Cost and Financial Aid
    • Student Resources
  • Research
    • Research Innovation
    • Conducting Research
    • Core Facilities
    • Research Centers
    • Research Training
    • Academic Departments
    • Find a Researcher
    • Research News
  • Clinical Experience
    • Where We Work
    • Caring for a Diverse Population
    • Faculty Clinical Experience
    • Advanced Patient Care
    • Academic Departments
    • Community Learning
  • Giving
  • Directory

Directory section navigation

  • Faculty Profiles

Emory University School of Medicine

  • About
    • Sub link
      Our Vision
    • Sub link
      Academic Departments
    • Sub link
      Our Leadership
    • Sub link
      Health Care Partnerships
    • Sub link
      Diversity, Equity, & Inclusion
    • Sub link
      Location
    • Sub link
      Supporting Our People
    • Sub link
      Our Faculty
    • Sub link
      History
    • Sub link
      News
    • Sub link
      Events
    • Sub link
      Contact Us
  • Education
    • Sub link
      Degree and Certificate Programs
    • Sub link
      Academic Departments
    • Sub link
      Residents & Fellows
    • Sub link
      Postdoctoral Training
    • Sub link
      Continuing Medical Education
    • Sub link
      Admissions
    • Sub link
      Cost and Financial Aid
    • Sub link
      Student Resources
  • Research
    • Sub link
      Research Innovation
    • Sub link
      Conducting Research
    • Sub link
      Core Facilities
    • Sub link
      Research Centers
    • Sub link
      Research Training
    • Sub link
      Academic Departments
    • Sub link
      Find a Researcher
    • Sub link
      Research News
  • Clinical Experience
    • Sub link
      Where We Work
    • Sub link
      Caring for a Diverse Population
    • Sub link
      Faculty Clinical Experience
    • Sub link
      Advanced Patient Care
    • Sub link
      Academic Departments
    • Sub link
      Community Learning
  • Giving
  • Directory
  • Home School of Medicine Home
  • Directory

Profile

Laurence Busse MD

  • Department of Medicine
    Associate Professor
  • laurence.w.busse@emory.edu
  • Website
  • Emory Johns Creek Hospital
    Intensive Care Unit
    6325 Hospital Parkway
Head shot of Laurence Busse

Overview

Dr. Busse completed his medical education at George Washington University, where he stayed on for his Internal Medicine residency, and fellowship training in Critical Care Medicine. He worked as an Intensivist in northern Virginia before joining Emory University in 2016 as the Medical Director of critical care at Emory Saint Josephs Hospital. He currently serves as Medical Director for critical care at Emory Johns Creek Hospital. Prior to his medical career, Dr. Busse received his Masters degree in Business Administration from Emory University. Dr. Busses areas of research and interest include the examination of the sequelae of high output shock, including catecholamine resistant hypotension and acute kidney injury. He has been involved in early clinical work exploring the use of angiotensin II as a novel therapeutic agent in catecholamine resistant hypotension. He is actively engaged as an intensivist and supervises trainees in Emory Johns Creek Hospitals intensive care unit.

Academic Appointment

  • Assistant Professor, Pulmonary, Critical Care, Allergy and Sleep Medicine, Emory University

Education

Degrees

  • M.D. from George Washington University
  • M.B.A. from Emory University
  • B.A. from Tulane University

Research

Publications

  • Modulation of the renin-angiotensin system against COVID-19: A path forward?
    Int J Infect Dis Volume: 154 Page(s): 107867
    05/01/2025 Authors: Camelo S; Dioh W; Teixeira JP; Busse LW; Nair G; Plantefeve G; Morelot-Panzini C; Lobo SM; Self WH; Collins SP
  • Patient- and Community-Level Characteristics Associated With Respiratory Syncytial Virus Vaccination.
    JAMA Netw Open Volume: 8 Page(s): e252841
    04/01/2025 Authors: Surie D; Yuengling KA; Safdar B; Ginde AA; Peltan ID; Brown SM; Gaglani M; Ghamande S; Gottlieb RL; Columbus C
  • COVID-19 and influenza vaccine Hesitancy among adults hospitalized in the United States, 2019-2022.
    Vaccine Volume: 48 Page(s): 126806
    02/27/2025 Authors: Khan A; Zhu Y; Babcock HM; Busse LW; Duggal A; Exline MC; Gaglani M; Gibbs KW; Gong MN; Ginde AA
  • Effectiveness of the Original Monovalent Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccination Series Against Hospitalization for COVID-19-Associated Venous Thromboembolism.
    J Infect Dis Volume: 231 Page(s): 378 - 385
    02/20/2025 Authors: Hager DN; Zhu Y; Sohn I; Stubblefield WB; Streiff MB; Gaglani M; Steingrub JS; Duggal A; Felzer JR; O'Rourke M
  • An index of the initial blood pressure response to angiotensin II treatment and its association with clinical outcomes in vasodilatory shock.
    Crit Care Volume: 29 Page(s): 81
    02/19/2025 Authors: Leisman DE; Wieruszewski PM; Busse LW; Chawla LS; Hibbert KA; Handisides DR; Khanna AK; Ostermann M; McCurdy MT; Adams CD
  • Shock prediction with dipeptidyl peptidase-3 and renin (SPiDeR) in hypoxemic patients with COVID-19.
    J Crit Care Volume: 85 Page(s): 154950
    02/01/2025 Authors: Busse LW; Teixeira JP; Schaich CL; Ten Lohuis CC; Nielsen ND; Sturek JM; Merck LH; Self WH; Puskarich MA; Khan A
  • Higher circulating ACE2 and DPP3 but reduced ACE and angiotensinogen in hyperreninemic sepsis patients.
    Clin Sci (Lond) Volume: 139 Page(s): 43 - 53
    01/15/2025 Authors: Chappell MC; Schaich CL; Busse LW; Clark Files D; Martin GS; Sevransky JE; Hinson JS; Rothman RE; Khanna AK; Vitamin C, Thiamine and Steroids in Sepsis (VICTAS) Investigators
  • Benefit of early oseltamivir therapy for adults hospitalized with influenza A: an observational study.
    Clin Infect Dis
    11/28/2024 Authors: Lewis NM; Harker EJ; Grant LB; Zhu Y; Grijalva CG; Chappell JD; Rhoads JP; Baughman A; Casey JD; Blair PW
  • Effectiveness of Original Monovalent and Bivalent COVID-19 Vaccines Against COVID-19-Associated Hospitalization and Severe In-Hospital Outcomes Among Adults in the United States, September 2022-August 2023.
    Influenza Other Respir Viruses Volume: 18 Page(s): e70027
    11/01/2024 Authors: DeCuir J; Surie D; Zhu Y; Lauring AS; Gaglani M; McNeal T; Ghamande S; Peltan ID; Brown SM; Ginde AA
  • Stronger association of intact angiotensinogen with mortality than lactate or renin in critical illness: post-hoc analysis from the VICTAS trial.
    Crit Care Volume: 28 Page(s): 333
    10/14/2024 Authors: Chappell MC; Schaich CL; Busse LW; Martin GS; Sevransky JE; Hinson JK; Khanna AK; Vitamin C, Thiamine, Steroids in Sepsis (VICTAS) Investigators
  • ACE inhibitors and angiotensin receptor blockers differentially alter the response to angiotensin II treatment in vasodilatory shock.
    Crit Care Volume: 28 Page(s): 130
    04/18/2024 Authors: Leisman DE; Handisides DR; Busse LW; Chappell MC; Chawla LS; Filbin MR; Goldberg MB; Ham KR; Khanna AK; Ostermann M
  • The scientific rationale and study protocol for the DPP3, Angiotensin II, and Renin Kinetics in Sepsis (DARK-Sepsis) randomized controlled trial: serum biomarkers to predict response to angiotensin II versus standard-of-care vasopressor therapy in the treatment of septic shock.
    Trials Volume: 25 Page(s): 182
    03/12/2024 Authors: Teixeira JP; Perez Ingles D; Barton JB; Dean JT; Garcia P; Kunkel SJ; Sarangarm P; Weiss NK; Schaich CL; Busse LW
  • Association of Active Renin Content With Mortality in Critically Ill Patients: A Post hoc Analysis of the Vitamin C, Thiamine, and Steroids in Sepsis (VICTAS) Trial.
    Crit Care Med Volume: 52 Page(s): 441 - 451
    03/01/2024 Authors: Busse LW; Schaich CL; Chappell MC; McCurdy MT; Staples EM; Ten Lohuis CC; Hinson JS; Sevransky JE; Rothman RE; Wright DW
  • Interim Estimates of 2023-24 Seasonal Influenza Vaccine Effectiveness - United States.
    MMWR Morb Mortal Wkly Rep Volume: 73 Page(s): 168 - 174
    02/29/2024 Authors: Frutos AM; Price AM; Harker E; Reeves EL; Ahmad HM; Murugan V; Martin ET; House S; Saade EA; Zimmerman RK
  • Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged 18 Years - VISION and IVY Networks, September 2023-January 2024.
    MMWR Morb Mortal Wkly Rep Volume: 73 Page(s): 180 - 188
    02/29/2024 Authors: DeCuir J; Payne AB; Self WH; Rowley EAK; Dascomb K; DeSilva MB; Irving SA; Grannis SJ; Ong TC; Klein NP
  • Major Publications in the Critical Care Pharmacotherapy Literature: 2022.
    Crit Care Explor Volume: 5 Page(s): e0981
    10/01/2023 Authors: Gurnani PK; Barlow B; Boling B; Busse LW; Diaz-Gomez JL; Ford J; Gibson GA; Khanna AK; Lee JS; Rivosecchi RM
  • Rethinking Vasopressor Education: The Need to Avoid Teaching the Bare Minimum.
    ATS Sch Volume: 4 Page(s): 389 - 390
    09/01/2023 Authors: McCurdy MT; Busse LW
  • Changing Severity and Epidemiology of Adults Hospitalized With Coronavirus Disease 2019 (COVID-19) in the United States After Introduction of COVID-19 Vaccines, March 2021-August 2022.
    Clin Infect Dis Volume: 77 Page(s): 547 - 557
    08/22/2023 Authors: Kojima N; Adams K; Self WH; Gaglani M; McNeal T; Ghamande S; Steingrub JS; Shapiro NI; Duggal A; Busse LW
  • Total and Subgenomic RNA Viral Load in Patients Infected With SARS-CoV-2 Alpha, Delta, and Omicron Variants.
    J Infect Dis Volume: 228 Page(s): 235 - 244
    08/11/2023 Authors: Dimcheff DE; Blair CN; Zhu Y; Chappell JD; Gaglani M; McNeal T; Ghamande S; Steingrub JS; Shapiro NI; Duggal A
  • Comparison of mRNA vaccine effectiveness against COVID-19-associated hospitalization by vaccination source: Immunization information systems, electronic medical records, and self-report-IVY Network, February 1-August 31, 2022.
    Vaccine Volume: 41 Page(s): 4249 - 4256
    06/29/2023 Authors: Surie D; Bonnell LN; DeCuir J; Gaglani M; McNeal T; Ghamande S; Steingrub JS; Shapiro NI; Busse LW; Prekker ME
  • Initiating angiotensin II at lower vasopressor doses in vasodilatory shock: an exploratory post-hoc analysis of the ATHOS-3 clinical trial.
    Crit Care Volume: 27 Page(s): 175
    05/05/2023 Authors: Wieruszewski PM; Bellomo R; Busse LW; Ham KR; Zarbock A; Khanna AK; Deane AM; Ostermann M; Wunderink RG; Boldt DW
  • Angiotensin II for Vasodilatory Hypotension in Patients Requiring Mechanical Circulatory Support.
    J Intensive Care Med Volume: 38 Page(s): 464 - 471
    05/01/2023 Authors: Wieruszewski PM; Seelhammer TG; Barreto EF; Busse LW; Chow JH; Davison DL; Gaglani B; Khanna AK; Ten Lohuis CC; Mara KC
  • Renin-Angiotensin System Modulation With Synthetic Angiotensin (1-7) and Angiotensin II Type 1 Receptor-Biased Ligand in Adults With COVID-19: Two Randomized Clinical Trials.
    JAMA Volume: 329 Page(s): 1170 - 1182
    04/11/2023 Authors: Self WH; Shotwell MS; Gibbs KW; de Wit M; Files DC; Harkins M; Hudock KM; Merck LH; Moskowitz A; Apodaca KD
  • Protection of Messenger RNA Vaccines Against Hospitalized Coronavirus Disease 2019 in Adults Over the First Year Following Authorization in the United States.
    Clin Infect Dis Volume: 76 Page(s): e460 - e468
    02/08/2023 Authors: Tenforde MW; Self WH; Zhu Y; Naioti EA; Gaglani M; Ginde AA; Jensen K; Talbot HK; Casey JD; Mohr NM
  • Anticoagulation practices for continuous renal replacement therapy: a survey of physicians from the United States.
    Ren Fail Volume: 45 Page(s): 2290932
    01/01/2023 Authors: Boldt D; Busse L; Chawla LS; Flannery AH; Khanna A; Neyra JA; Palmer P; Wilson J; Yessayan L
  • Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021-April 2022.
    Open Forum Infect Dis Volume: 10 Page(s): ofac698
    01/01/2023 Authors: Lewis NM; Murray N; Adams K; Surie D; Gaglani M; Ginde AA; McNeal T; Ghamande S; Douin DJ; Talbot HK
  • Comparison of test-negative and syndrome-negative controls in SARS-CoV-2 vaccine effectiveness evaluations for preventing COVID-19 hospitalizations in the United States.
    Vaccine Volume: 40 Page(s): 6979 - 6986
    11/15/2022 Authors: Turbyfill C; Adams K; Tenforde MW; Murray NL; Gaglani M; Ginde AA; McNeal T; Ghamande S; Douin DJ; Keipp Talbot H
  • Ascertainment of vaccination status by self-report versus source documentation: Impact on measuring COVID-19 vaccine effectiveness.
    Influenza Other Respir Viruses Volume: 16 Page(s): 1101 - 1111
    11/01/2022 Authors: Stephenson M; Olson SM; Self WH; Ginde AA; Mohr NM; Gaglani M; Shapiro NI; Gibbs KW; Hager DN; Prekker ME
  • Vaccine effectiveness of primary series and booster doses against covid-19 associated hospital admissions in the United States: living test negative design study.
    BMJ Volume: 379 Page(s): e072065
    10/11/2022 Authors: Adams K; Rhoads JP; Surie D; Gaglani M; Ginde AA; McNeal T; Talbot HK; Casey JD; Zepeski A; Shapiro NI
  • Effectiveness of the Ad26.COV2.S (Johnson & Johnson) Coronavirus Disease 2019 (COVID-19) Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United States.
    Clin Infect Dis Volume: 75 Page(s): S159 - S166
    10/03/2022 Authors: Lewis NM; Self WH; Gaglani M; Ginde AA; Douin DJ; Keipp Talbot H; Casey JD; Mohr NM; Zepeski A; Ghamande SA
  • mRNA Vaccine Effectiveness Against Coronavirus Disease 2019 Hospitalization Among Solid Organ Transplant Recipients.
    J Infect Dis Volume: 226 Page(s): 797 - 807
    09/13/2022 Authors: Kwon JH; Tenforde MW; Gaglani M; Talbot HK; Ginde AA; McNeal T; Ghamande S; Douin DJ; Casey JD; Mohr NM
  • Effectiveness of mRNA Vaccines Against COVID-19 Hospitalization by Age and Chronic Medical Conditions Burden Among Immunocompetent US Adults, March-August 2021.
    J Infect Dis Volume: 225 Page(s): 1694 - 1700
    05/16/2022 Authors: Lewis NM; Naioti EA; Self WH; Ginde AA; Douin DJ; Keipp Talbot H; Casey JD; Mohr NM; Zepeski A; Gaglani M
  • Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines for Preventing Coronavirus Disease 2019 Hospitalizations in the United States.
    Clin Infect Dis Volume: 74 Page(s): 1515 - 1524
    05/03/2022 Authors: Tenforde MW; Patel MM; Ginde AA; Douin DJ; Talbot HK; Casey JD; Mohr NM; Zepeski A; Gaglani M; McNeal T
  • Protocol Compliance Guiding Angiotensin II Use in Post Cardiovascular Surgery Vasoplegia.
    Crit Care Explor Volume: 4 Page(s): e0687
    05/01/2022 Authors: Ten Lohuis CC; Burke SC; Jannuzzo CJ; Barker NA; Chen EP; Busse LW
  • Effectiveness of mRNA Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death - United States, March 2021-January 2022.
    MMWR Morb Mortal Wkly Rep Volume: 71 Page(s): 459 - 465
    03/25/2022 Authors: Tenforde MW; Self WH; Gaglani M; Ginde AA; Douin DJ; Talbot HK; Casey JD; Mohr NM; Zepeski A; McNeal T
  • Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study.
    BMJ Volume: 376 Page(s): e069761
    03/09/2022 Authors: Lauring AS; Tenforde MW; Chappell JD; Gaglani M; Ginde AA; McNeal T; Ghamande S; Douin DJ; Talbot HK; Casey JD
  • Trends in ICU Mortality From Coronavirus Disease 2019: A Tale of Three Surges.
    Crit Care Med Volume: 50 Page(s): 245 - 255
    02/01/2022 Authors: Auld SC; Harrington KRV; Adelman MW; Robichaux CJ; Overton EC; Caridi-Scheible M; Coopersmith CM; Murphy DJ; Emory COVID-19 Quality and Clinical Research Collaborative
  • Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults - United States, August-December 2021.
    MMWR Morb Mortal Wkly Rep Volume: 71 Page(s): 118 - 124
    01/28/2022 Authors: Tenforde MW; Patel MM; Gaglani M; Ginde AA; Douin DJ; Talbot HK; Casey JD; Mohr NM; Zepeski A; McNeal T
  • Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity.
    JAMA Volume: 326 Page(s): 2043 - 2054
    11/23/2021 Authors: Tenforde MW; Self WH; Adams K; Gaglani M; Ginde AA; McNeal T; Ghamande S; Douin DJ; Talbot HK; Casey JD
  • Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021.
    MMWR Morb Mortal Wkly Rep Volume: 70 Page(s): 1337 - 1343
    09/24/2021 Authors: Self WH; Tenforde MW; Rhoads JP; Gaglani M; Ginde AA; Douin DJ; Olson SM; Talbot HK; Casey JD; Mohr NM
  • Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults - United States, March-July 2021.
    MMWR Morb Mortal Wkly Rep Volume: 70 Page(s): 1156 - 1162
    08/27/2021 Authors: Tenforde MW; Self WH; Naioti EA; Ginde AA; Douin DJ; Olson SM; Talbot HK; Casey JD; Mohr NM; Zepeski A
  • Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United States.
    medRxiv
    07/08/2021 Authors: Tenforde MW; Patel MM; Ginde AA; Douin DJ; Talbot HK; Casey JD; Mohr NM; Zepeski A; Gaglani M; McNeal T
  • Effect of Vitamin C, Thiamine, and Hydrocortisone on Ventilator- and Vasopressor-Free Days in Patients With Sepsis: The VICTAS Randomized Clinical Trial.
    JAMA Volume: 325 Page(s): 742 - 750
    02/23/2021 Authors: Sevransky JE; Rothman RE; Hager DN; Bernard GR; Brown SM; Buchman TG; Busse LW; Coopersmith CM; DeWilde C; Ely EW
  • New strategies to optimize renal haemodynamics.
    Curr Opin Crit Care Volume: 26 Page(s): 536 - 542
    12/01/2020 Authors: Suarez J; Busse LW
  • Renin and Survival in Patients Given Angiotensin II for Catecholamine-Resistant Vasodilatory Shock. A Clinical Trial.
    Am J Respir Crit Care Med Volume: 202 Page(s): 1253 - 1261
    11/01/2020 Authors: Bellomo R; Forni LG; Busse LW; McCurdy MT; Ham KR; Boldt DW; Hstbacka J; Khanna AK; Albertson TE; Tumlin J
  • In response: Letter on update to the Vitamin C, Thiamine and Steroids in Sepsis (VICTAS) protocol.
    Trials Volume: 21 Page(s): 351
    04/22/2020 Authors: Lindsell CJ; McGlothlin A; Nwosu S; Rice TW; Hall A; Bernard GR; Busse LW; Ely EW; Fowler AA; Gaieski DF
  • COVID-19 and the RAAS-a potential role for angiotensin II?
    Crit Care Volume: 24 Page(s): 136
    04/07/2020 Authors: Busse LW; Chow JH; McCurdy MT; Khanna AK
  • Angiotensin II for the treatment of distributive shock in the intensive care unit: A US cost-effectiveness analysis.
    Int J Technol Assess Health Care Volume: 36 Page(s): 145 - 151
    04/01/2020 Authors: Busse LW; Nicholson G; Nordyke RJ; Lee C-H; Zeng F; Albertson TE
  • Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock.
    Crit Care Volume: 24 Page(s): 43
    02/06/2020 Authors: Bellomo R; Wunderink RG; Szerlip H; English SW; Busse LW; Deane AM; Khanna AK; McCurdy MT; Ostermann M; Young PJ
  • Vasoplegic syndrome following cardiothoracic surgery-review of pathophysiology and update of treatment options.
    Crit Care Volume: 24 Page(s): 36
    02/04/2020 Authors: Busse LW; Barker N; Petersen C
  • ANGIOTENSIN II USE IN ANGIOTENSIN RECEPTOR BLOCKER OVERDOSE
    CRITICAL CARE MEDICINE Volume: 48
    01/01/2020 Authors: Goodwin E; Swenson C; Busse L; Tendler R; Sharifpour M; VanAcker C; Daniels C
  • Update to the Vitamin C, Thiamine and Steroids in Sepsis (VICTAS) protocol: statistical analysis plan for a prospective, multicenter, double-blind, adaptive sample size, randomized, placebo-controlled, clinical trial.
    Trials Volume: 20 Page(s): 670
    12/04/2019 Authors: Lindsell CJ; McGlothlin A; Nwosu S; Rice TW; Hall A; Bernard GR; Busse LW; Ely EW; Fowler AA; Gaieski DF
  • Just a Little Off the Top, Please.
    Crit Care Med Volume: 47 Page(s): 1810 - 1813
    12/01/2019 Authors: Busse LW
  • Vasopressor Therapy and Blood Pressure Management in the Setting of Acute Kidney Injury.
    Semin Nephrol Volume: 39 Page(s): 462 - 472
    09/01/2019 Authors: Busse LW; Ostermann M
  • Successful Treatment of Antihypertensive Overdose Using Intravenous Angiotensin II.
    J Emerg Med Volume: 57 Page(s): 339 - 344
    09/01/2019 Authors: Carpenter JE; Murray BP; Saghafi R; Thomas B; Lee S; Kleiman R; Punja M; Silver E; Busse LW
  • Sensitivity to angiotensin II dose in patients with vasodilatory shock: a prespecified analysis of the ATHOS-3 trial.
    Ann Intensive Care Volume: 9 Page(s): 63
    06/03/2019 Authors: Ham KR; Boldt DW; McCurdy MT; Busse LW; Favory R; Gong MN; Khanna AK; Chock SN; Zeng F; Chawla LS
  • Angiotensin II: Time to Study Starting a Stopped Heart.
    Crit Care Med Volume: 47 Page(s): e436
    05/01/2019 Authors: McCurdy MT; Khanna AK; Busse LW
  • The Vitamin C, Thiamine and Steroids in Sepsis (VICTAS) Protocol: a prospective, multi-center, double-blind, adaptive sample size, randomized, placebo-controlled, clinical trial.
    Trials Volume: 20 Page(s): 197
    04/05/2019 Authors: Hager DN; Hooper MH; Bernard GR; Busse LW; Ely EW; Fowler AA; Gaieski DF; Hall A; Hinson JS; Jackson JC
  • Angiotensin II in Vasodilatory Shock.
    Crit Care Clin Volume: 35 Page(s): 229 - 245
    04/01/2019 Authors: Wakefield BJ; Busse LW; Khanna AK
  • Regional differences in the treatment of refractory vasodilatory shock using Angiotensin II in High Output Shock (ATHOS-3) data.
    J Crit Care Volume: 50 Page(s): 188 - 194
    04/01/2019 Authors: Abril MK; Khanna AK; Kroll S; McNamara C; Handisides D; Busse LW
  • Sepsis Updates: Unpackaging the New Bundles.
    Int Anesthesiol Clin Volume: 57 Page(s): 3 - 16
    01/01/2019 Authors: Busse LW; Spiegel RJ; Karambelkar A; McCurdy MT
  • Response.
    Chest Volume: 155 Page(s): 242 - 243
    01/01/2019 Authors: Jentzer JC; Vallabhajosyula S; Khanna AK; Chawla LS; Busse LW; Kashani KB
  • Management of Refractory Vasodilatory Shock.
    Chest Volume: 154 Page(s): 416 - 426
    08/01/2018 Authors: Jentzer JC; Vallabhajosyula S; Khanna AK; Chawla LS; Busse LW; Kashani KB
  • Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin II.
    Crit Care Med Volume: 46 Page(s): 949 - 957
    06/01/2018 Authors: Tumlin JA; Murugan R; Deane AM; Ostermann M; Busse LW; Ham KR; Kashani K; Szerlip HM; Prowle JR; Bihorac A
  • Angiotensin in Critical Care.
    Crit Care Volume: 22 Page(s): 69
    03/20/2018 Authors: Hall A; Busse LW; Ostermann M
  • Angiotensin II: a new therapeutic option for vasodilatory shock.
    Ther Clin Risk Manag Volume: 14 Page(s): 1287 - 1298
    01/01/2018 Authors: Bussard RL; Busse LW
  • The effect of angiotensin II on blood pressure in patients with circulatory shock: a structured review of the literature.
    Crit Care Volume: 21 Page(s): 324
    12/28/2017 Authors: Busse LW; McCurdy MT; Ali O; Hall A; Chen H; Ostermann M
  • Novel Therapies for Acute Kidney Injury.
    Kidney Int Rep Volume: 2 Page(s): 785 - 799
    09/01/2017 Authors: Chen H; Busse LW
  • Angiotensin II for the Treatment of Vasodilatory Shock.
    N Engl J Med Volume: 377 Page(s): 419 - 430
    08/03/2017 Authors: Khanna A; English SW; Wang XS; Ham K; Tumlin J; Szerlip H; Busse LW; Altaweel L; Albertson TE; Mackey C
  • Clinical Experience With IV Angiotensin II Administration: A Systematic Review of Safety.
    Crit Care Med Volume: 45 Page(s): 1285 - 1294
    08/01/2017 Authors: Busse LW; Wang XS; Chalikonda DM; Finkel KW; Khanna AK; Szerlip HM; Yoo D; Dana SL; Chawla LS
  • The use of angiotensin II in distributive shock.
    Crit Care Volume: 20 Page(s): 137
    05/27/2016 Authors: Chawla LS; Busse LW; Brasha-Mitchell E; Alotaibi Z
  • Side Effects and Adverse Events Associated With Intravenous Angiotensin II in Humans: A Systematic Review and Meta-analysis
    CHEST Volume: 148
    10/01/2015 Authors: Chalikonda D; Busse L; Yoo D; Chawla L
  • Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study.
    Crit Care Volume: 18 Page(s): 534
    10/06/2014 Authors: Chawla LS; Busse L; Brasha-Mitchell E; Davison D; Honiq J; Alotaibi Z; Seneff MG
  • Submassive pulmonary embolism.
    Crit Care Clin Volume: 30 Page(s): 447 - 473
    07/01/2014 Authors: Busse LW; Vourlekis JS
  • Hemodynamic monitoring in the critical care environment.
    Adv Chronic Kidney Dis Volume: 20 Page(s): 21 - 29
    01/01/2013 Authors: Busse L; Davison DL; Junker C; Chawla LS
Read more publications Fewer publications
Directory
  • Faculty Profiles
Emory University Homepage

Contact & Location

Emory University School of Medicine
100 Woodruff Circle
Atlanta, GA  30322 USA
  • Contact Us
  • Maps & Directions
  • Careers

Information For

  • Alumni
  • Faculty & Staff
  • Patients
  • Residents & Fellows
  • Students
Support the School of Medicine School of Medicine Intranet
facebook facebook twitter twitter linkedin linkedin instagram instagram youtube youtube
© 2025 Emory University
  • Privacy Policy
  • Emergency Information
  • EEO Employer-Disability/Veteran Statements